What is pulseData?
Founded in 2020, pulseData operates at the intersection of data science and clinical outcomes. The company provides a sophisticated suite of AI-driven solutions that identify and predict health trajectories for patients suffering from complex, long-term conditions. By integrating disparate clinical data points, pulseData enables healthcare providers to transition from reactive treatment models to predictive, preventative care strategies. This market position is increasingly vital as the healthcare industry shifts toward value-based reimbursement models, where the ability to accurately forecast patient needs directly correlates with improved clinical outcomes and reduced systemic costs. The firm's technology serves as the connective tissue between raw health data and actionable clinical workflows.
How much funding has pulseData raised?
pulseData has raised a total of $16.6M across 2 funding rounds:
Debt
$150K
Series A
$16.5M
Debt (2020): $150K with participation from PPP
Series A (2021): $16.5M led by Two Bear Capital, Alumni Ventures, and Bain Capital
Key Investors in pulseData
Two Bear Capital
A venture capital firm focused on backing early-stage companies that leverage deep technology to solve significant global challenges.
Alumni Ventures
Headquartered in Manchester, New Hampshire, Alumni Ventures Group creates and manages alumni venture capital funds at top colleges and universities, providing a structured approach to early-stage investment.
Bain Capital
A leading global private investment firm that applies deep sector expertise and broad capabilities across private equity, venture, and credit markets to drive innovation and exceptional outcomes.
What's next for pulseData?
With the recent capital injection, pulseData is poised to expand its operational footprint and enhance its predictive modeling capabilities. The strategic focus will likely center on deepening integration with existing electronic health record systems and broadening the scope of its cardiorenal comorbidity analysis. As the company matures, the emphasis will remain on scaling its value-based care infrastructure to support larger health systems and payer networks. By maintaining its trajectory of innovation, pulseData is well-positioned to influence the future of chronic disease management, potentially setting new standards for how predictive analytics are utilized to optimize patient health and operational efficiency in the modern medical landscape.
See full pulseData company page
